{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:44:19Z","timestamp":1792071859118,"version":"4.4.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06244-4","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T21:55:41Z","timestamp":1750456541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mesenchymal stem cells in the bone marrow microenvironment: a double-edged sword for AML"],"prefix":"10.1007","volume":"151","author":[{"given":"Mohamed J.","family":"Saadh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7843-0717","authenticated-orcid":false,"given":"Nima","family":"Torabi Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5079-0651","authenticated-orcid":false,"given":"Amirhossein","family":"Mirzazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3477-5793","authenticated-orcid":false,"given":"Mohammad","family":"Siavashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4549-956X","authenticated-orcid":false,"given":"Fatemeh","family":"SeyedMoharami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekoofeh","family":"Noroozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-7613","authenticated-orcid":false,"given":"Hamed","family":"Soleimani Samarkhazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"6244_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s11658-022-00366-0","volume":"27","author":"M Al-Azab","year":"2022","unstructured":"Al-Azab M, Safi M, Idiiatullina E, Al-Shaebi F, Mohamed Y, Zaky (2022) Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting. Cell Mol Biol Lett 27:69","journal-title":"Cell Mol Biol Lett"},{"key":"6244_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12935-021-01836-9","volume":"21","author":"S Aravindhan","year":"2021","unstructured":"Aravindhan S, Ejam SS, Lafta MH, Markov A, Yumashev AV, Ahmadi M (2021a) Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature. Cancer Cell Int 21:158","journal-title":"Cancer Cell Int"},{"key":"6244_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12935-021-01836-9","volume":"21","author":"S Aravindhan","year":"2021","unstructured":"Aravindhan S, Ejam SS, Lafta MH, Markov A, Yumashev AV, Majid Ahmadi (2021b) Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature. Cancer Cell Int 21:158","journal-title":"Cancer Cell Int"},{"key":"6244_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12185-017-2262-9","volume":"106","author":"N Asada","year":"2017","unstructured":"Asada N, Takeishi S, Frenette PS (2017) Complexity of bone marrow hematopoietic stem cell niche. Int J Hematol 106:45\u201354","journal-title":"Int J Hematol"},{"key":"6244_CR5","doi-asserted-by":"crossref","unstructured":"Aval O, Ahmadi A, Al-Athari A, Samarkhazan H, Chafi F, Asadi M, Mohammadi M, and Mojtaba Aghaei (2025). \u2018Galectin-9: A double-edged sword in Acute Myeloid Leukemia\u2019. Ann Hematol: 1\u201314","DOI":"10.1007\/s00277-025-06387-x"},{"key":"6244_CR6","doi-asserted-by":"crossref","unstructured":"Barakos GP, Hatzimichael E (2022) \u2018Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia\u2019, Diseases, 10","DOI":"10.3390\/diseases10020033"},{"key":"6244_CR7","doi-asserted-by":"crossref","unstructured":"Barthes J, \u00d6z\u00e7elik H, Hindi\u00e9 M, Ndreu-Halili A, Hasan A, Vrana NE (2014) \u2018Cell microenvironment engineering and monitoring for tissue engineering and regenerative medicine: the recent advances\u2019, Biomed Res Int, 2014: 921905","DOI":"10.1155\/2014\/921905"},{"key":"6244_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.13016","volume":"1370","author":"A Birbrair","year":"2016","unstructured":"Birbrair A, Frenette PS (2016) Niche heterogeneity in the bone marrow. Ann N Y Acad Sci 1370:82\u201396","journal-title":"Ann N Y Acad Sci"},{"key":"6244_CR9","doi-asserted-by":"crossref","unstructured":"Bishoyi AK, Nouri S, Hussen A, Bayani A, Khaksari MN and H. Soleimani Samarkhazan. 2025. \u2018Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation\u2019. Clin Exp Med, 25: 166","DOI":"10.1007\/s10238-025-01686-z"},{"key":"6244_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fimmu.2017.00106","volume":"8","author":"AK Brenner","year":"2017","unstructured":"Brenner AK, Nepstad I, Bruserud \u00d8 (2017) Mesenchymal stem cells support survival and proliferation of primary human acute myeloid leukemia cells through heterogeneous molecular mechanisms. Front Immunol 8:106","journal-title":"Front Immunol"},{"key":"6244_CR11","doi-asserted-by":"crossref","unstructured":"Carpenter VJ, Saleh T, Gewirtz DA (2021) \u2018Senolytics for Cancer Therapy: Is All That Glitters Really Gold?\u2018. Cancers (Basel), 13","DOI":"10.3390\/cancers13040723"},{"key":"6244_CR12","doi-asserted-by":"crossref","unstructured":"Chen SL, Qin ZY, Hu F, Wang Y, Dai YJ, Liang Y (2019) \u2018The Role of the HOXA Gene Family in Acute Myeloid Leukemia\u2019. Genes (Basel), 10","DOI":"10.3390\/genes10080621"},{"key":"6244_CR13","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/cbin.11790","volume":"46","author":"MS Choudhery","year":"2022","unstructured":"Choudhery MS, Mahmood R, Harris DT, Ahmad FJ (2022) Minimum criteria for defining induced mesenchymal stem cells. Cell Biol Int 46:986\u2013989","journal-title":"Cell Biol Int"},{"key":"6244_CR14","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M (2016) \u2018Acute myeloid leukemia: a comprehensive review and 2016 update\u2019. Blood Cancer J 6:e441","journal-title":"Blood Cancer J"},{"key":"6244_CR15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.stemcr.2017.04.019","volume":"8","author":"R de la Diaz","year":"2017","unstructured":"de la Diaz R, Lopez-Millan B, Lavoie JR, Bueno C, Casta\u00f1o J, G\u00f3mez-Casares M, Vives S, Palomo L, Juan M, Delgado J, Blanco ML, Nomdedeu J, Chaparro A, Fuster JL, Anguita E, Rosu-Myles M, Men\u00e9ndez P (2017) Detailed characterization of mesenchymal stem\/stromal cells from a large cohort of AML patients demonstrates a definitive link to treatment outcomes. Stem Cell Rep 8:1573\u20131586","journal-title":"Stem Cell Rep"},{"key":"6244_CR16","unstructured":"Farrokhi M, Taheri F, Khouzani PJ, Rahmani E, Tavakoli R, Fard AM, Rajabloo Y (2023) Atieh Sadeghniiat-Haghighi, Kimia Shahbazi, Mohammadsadegh Aghabababak Semnani, Mahdokht Sadat Manavi, Marzieh Rohaninasab, Golsa Babapour, Zahra Mohammadi, Mohammad Pirouzan, Zahra Pirouzan, Sahar Hassantash, Sina Safdari, Habibollah Afshang, Vahid Jafari, Negar Pourhossein Rahmani, Setareh Yousefi, Ali Shamsi-Goushki, Mehran Khodashenas, Mahshid Esmaielzade Rostami, Hamed Soleimani Samarkhazan, Roya Khorram, and Kosar Sadoughi. \u2018Role of Precision Medicine and Personalized Medicine in the Treatment of Diseases\u2019, Kindle, 3: 1-164"},{"key":"6244_CR17","doi-asserted-by":"publisher","first-page":"e0215678","DOI":"10.1371\/journal.pone.0215678","volume":"14","author":"E Fathi","year":"2019","unstructured":"Fathi E, Farahzadi R, Valipour B, Sanaat Z (2019) Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation. PLoS ONE 14:e0215678","journal-title":"PLoS ONE"},{"key":"6244_CR18","doi-asserted-by":"crossref","unstructured":"Fracchiolla NS, Fattizzo B, Cortelezzi A (2017) \u2018Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications\u2019, Stem Cells Int, 2017: 6720594","DOI":"10.1155\/2017\/6720594"},{"key":"6244_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/CJI.0000000000000250","volume":"42","author":"B Grzywacz","year":"2019","unstructured":"Grzywacz B, Moench L, McKenna D Jr., Tessier KM, Bachanova V, Cooley S, Miller JS, Courville EL (2019) Natural killer cell homing and persistence in the bone marrow after adoptive immunotherapy correlates with better leukemia control. J Immunother 42:65\u201372","journal-title":"J Immunother"},{"key":"6244_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.21037\/tcr-22-27","volume":"11","author":"Y Guo","year":"2022","unstructured":"Guo Y, Wang W, Sun H (2022) A systematic review and meta-analysis on the risk factors of acute myeloid leukemia. Transl Cancer Res 11:796\u2013804","journal-title":"Transl Cancer Res"},{"key":"6244_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40364-023-00529-x","volume":"11","author":"X Guo","year":"2023","unstructured":"Guo X, Can C, Liu W, Wei Y, Yang X, Liu J, Jia H, Jia W, Wu H, Ma D (2023) Mitochondrial transfer in hematological malignancies. Biomark Res 11:89","journal-title":"Biomark Res"},{"key":"6244_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, Hua D, Shao C, Yufang Shi (2022) The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther 7:92","journal-title":"Signal Transduct Target Ther"},{"key":"6244_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.20.00475","volume":"39","author":"S Khaldoyanidi","year":"2021","unstructured":"Khaldoyanidi S, Nagorsen D, Stein A, Ossenkoppele G, Subklewe M (2021) Immune biology of acute myeloid leukemia: implications for immunotherapy. J Clin Oncol 39:419\u2013432","journal-title":"J Clin Oncol"},{"key":"6244_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.61186\/ibj.27.5.247","volume":"27","author":"M Khani-Eshratabadi","year":"2023","unstructured":"Khani-Eshratabadi M, Mousavi SH, Zarrabi M, Khanmiri JM, Zeinali Bardar Z (2023) Human umbilical cord mesenchymal stem Cell-Derived microvesicles could induce apoptosis and autophagy in acute myeloid leukemia. Iran Biomed J 27:247\u2013256","journal-title":"Iran Biomed J"},{"key":"6244_CR25","doi-asserted-by":"crossref","unstructured":"Kubaev A, Faez Sead F, Pirouzbakht M, Nazari M, Riyahi H, Sargazi Aval O, Hasanvand A, Mousavi F and H. Soleimani Samarkhazan. 2025. \u2018Platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis\u2019. J Liposome Res: 1\u201311","DOI":"10.1080\/08982104.2025.2495261"},{"key":"6244_CR27","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/jbmr.3106","volume":"32","author":"RA Lawal","year":"2017","unstructured":"Lawal RA, Xichao Zhou K, Batey, Corey M, Hoffman MA, Georger F, Radtke MJ, Hilton L, Xing BJ, Frisch, Laura M Calvi (2017b) The Notch ligand Jagged1 regulates the osteoblastic lineage by maintaining the osteoprogenitor pool. J Bone Miner Res 32:1320\u20131331","journal-title":"J Bone Miner Res"},{"key":"6244_CR26","doi-asserted-by":"crossref","unstructured":"Lawal RA, Zhou X, Batey K, Hoffman CM, Georger MA, Radtke F, Hilton MJ, Xing L, Frisch BJ and L. M. Calvi. 2017a. \u2018The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool\u2019. J Bone Min Res, 32: 1320\u20131331","DOI":"10.1002\/jbmr.3106"},{"key":"6244_CR28","unstructured":"Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, Hoadley K, Triche TJ Jr., Laird PW, Baty JD, Fulton LL, Fulton R, Heath SE, Kalicki-Veizer J, Kandoth C, Klco JM, Koboldt DC, Kanchi KL, Kulkarni S, Lamprecht TL, Larson DE, Lin L, Lu C, McLellan MD, McMichael JF, Payton J, Schmidt H, Spencer DH, Tomasson MH, Wallis JW, Wartman LD, Watson MA, Welch J, Wendl MC, Ally A, Balasundaram M, Birol I, Butterfield Y, Chiu R, Chu A, Chuah E, Chun HJ, Corbett R, Dhalla N, Guin R, He A, Hirst C, Hirst M, Holt RA, Jones S, Karsan A, Lee D, Li HI, Marra MA, Mayo M, Moore RA, Mungall K, Parker J, Pleasance E, Plettner P, Schein J, Stoll D, Swanson L, Tam A, Thiessen N, Varhol R, Wye N, Zhao Y, Gabriel S, Getz G, Sougnez C, Zou L, Leiserson MD, Vandin F, Wu HT, Applebaum F, Baylin SB, Akbani R, Broom BM, Chen K, Motter TC, Nguyen K, Weinstein JN, Zhang N, Ferguson ML, Adams C, Black A, Bowen J, Gastier-Foster J, Grossman T, Lichtenberg T, Wise L, Davidsen T, Demchok JA, Shaw KR, Sheth M, Sofia HJ, Yang L J. R. Downing, and G. Eley. 2013. \u2018Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia\u2019, N Engl J Med, 368: 2059\u20132074"},{"key":"6244_CR29","doi-asserted-by":"publisher","first-page":"1397005","DOI":"10.3389\/fimmu.2024.1397005","volume":"15","author":"K Li","year":"2024","unstructured":"Li K, Nie H, Jin R, Wu X (2024) Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy. Front Immunol 15:1397005","journal-title":"Front Immunol"},{"key":"6244_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Li W, Hu J, Lu C, Liu Y (2020) PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis 11:797","journal-title":"Cell Death Dis"},{"key":"6244_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13287-022-02985-y","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Gao J, Liang Z, Gao C, Niu Q, Wu F, Zhang L (2022) Mesenchymal stem cells and their microenvironment. Stem Cell Res Ther 13:429","journal-title":"Stem Cell Res Ther"},{"key":"6244_CR32","doi-asserted-by":"publisher","first-page":"40707","DOI":"10.1038\/srep40707","volume":"7","author":"MR Lopes","year":"2017","unstructured":"Lopes MR, Pereira JK, de Melo Campos P, Machado-Neto JA, Traina F, Saad ST, Favaro P (2017) De Novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes. Sci Rep 7:40707","journal-title":"Sci Rep"},{"key":"6244_CR33","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1111\/cas.15855","volume":"114","author":"J Lu","year":"2023","unstructured":"Lu J, Dong Q, Zhang S, Feng Y, Yang J, Zhao L (2023) Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6\/JAK2\/STAT3 signaling. Cancer Sci 114:3287\u20133300","journal-title":"Cancer Sci"},{"key":"6244_CR34","doi-asserted-by":"crossref","unstructured":"Luo C, He S, Shi F, Zhou J, Shang L (2024) \u2018The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies\u2019, Biology (Basel), 13","DOI":"10.3390\/biology13070521"},{"key":"6244_CR35","doi-asserted-by":"crossref","unstructured":"Maumus M, Rozier P, Boulestreau J\u00e9r\u00e9my, Jorgensen C, Dani\u00e8le No\u00ebl (2020) \u2018Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation\u2019. Front Bioeng Biotechnol, Volume 8\u20132020","DOI":"10.3389\/fbioe.2020.00997"},{"key":"6244_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12964-016-0143-0","volume":"14","author":"C Melzer","year":"2016","unstructured":"Melzer C, Yang Y, Hass R (2016a) Interaction of MSC with tumor cells. Cell Commun Signal 14:20","journal-title":"Cell Commun Signal"},{"key":"6244_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12964-016-0143-0","volume":"14","author":"C Melzer","year":"2016","unstructured":"Melzer C, Yang Y, Ralf Hass (2016b) Interaction of MSC with tumor cells. Cell Communication Signal 14:20","journal-title":"Cell Communication Signal"},{"key":"6244_CR38","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood.2022018092","volume":"141","author":"SK Mishra","year":"2023","unstructured":"Mishra SK, Millman SE, Zhang L (2023) Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets. Blood 141:1119\u20131135","journal-title":"Blood"},{"key":"6244_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1182\/asheducation-2017.1.37","volume":"2017","author":"M Moarii","year":"2017","unstructured":"Moarii M, Papaemmanuil E (2017) Classification and risk assessment in AML: integrating cytogenetics and molecular profiling. Hematol Am Soc Hematol Educ Program 2017:37\u201344","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"6244_CR40","doi-asserted-by":"crossref","unstructured":"Moschoi R, Imbert V, Nebout M, Chiche J, Mary D, Prebet T, Saland E, Castellano R, Pouyet L, Collette Y, Vey N, Chabannon C, Recher C, Sarry JE, Alcor D, Peyron JF and E. Griessinger. 2016. \u2018Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy\u2019, Blood, 128: 253\u2013\u200964","DOI":"10.1182\/blood-2015-07-655860"},{"key":"6244_CR42","doi-asserted-by":"crossref","unstructured":"Mussai F, Santo CD, Abu-Dayyeh I, Booth S, Quek L, Rosanna M, McEwen-Smith (2013b) Amrana Qureshi, Francesco Dazzi, Paresh Vyas, and Vincenzo Cerundolo. \u2018Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment\u2019, Blood, 122: 749\u2013\u200958","DOI":"10.1182\/blood-2013-01-480129"},{"key":"6244_CR41","doi-asserted-by":"crossref","unstructured":"Mussai F, De Santo C, Abu-Dayyeh I, Booth S, Quek L, McEwen-Smith RM, Qureshi A, Dazzi F, Vyas P, Cerundolo V 2013a. \u2018Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment\u2019, Blood, 122: 749\u2013\u200958","DOI":"10.1182\/blood-2013-01-480129"},{"key":"6244_CR43","first-page":"28","volume":"11","author":"HS Noroozi Aghide, Ali","year":"2016","unstructured":"Noroozi Aghide, Ali HS, Samarkhazan, Ahmadnezhad M (2016) Effect of Harmine alkaloid on the expression of P16 and DAPK in HL60 leukemia cell line. Paramedical Sci Military Health 11:28\u201333","journal-title":"Paramedical Sci Military Health"},{"key":"6244_CR44","doi-asserted-by":"publisher","first-page":"e93019","DOI":"10.7554\/eLife.93019","volume":"13","author":"K Nuno","year":"2024","unstructured":"Nuno K, Azizi A, Koehnke T, Lareau C, Ediriwickrema A, Ryan Corces M, Satpathy AT, Ravindra Majeti (2024) Convergent epigenetic evolution drives relapse in acute myeloid leukemia. Elife 13:e93019","journal-title":"Elife"},{"key":"6244_CR45","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/2211-5463.13165","volume":"11","author":"ZP Pan","year":"2021","unstructured":"Pan ZP, Wang B, Hou DY, You RL, Wang XT, Xie WH, Huang HF (2021) METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia. FEBS Open Bio 11:1659\u20131672","journal-title":"FEBS Open Bio"},{"key":"6244_CR46","doi-asserted-by":"crossref","unstructured":"Park A, Lee Y, Kim MS, Kang YJ, Park YJ, Jung H, Kim TD, Lee HG, Choi I and S. R. Yoon. 2018. \u2018Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation\u2019. Front Immunol, 9: 1859","DOI":"10.3389\/fimmu.2018.01859"},{"key":"6244_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3324\/haematol.2020.266155","volume":"107","author":"F Pepe","year":"2022","unstructured":"Pepe F, Bill M, Papaioannou D, Karunasiri M, Walker A, Naumann E, Snyder K, Ranganathan P, Dorrance A, Garzon R (2022) Targeting Wnt signaling in acute myeloid leukemia stem cells. Haematologica 107:307\u2013311","journal-title":"Haematologica"},{"key":"6244_CR48","doi-asserted-by":"crossref","unstructured":"Peta KT, Ambele MA, Pepper MS (2021) \u2018Similarities between Tumour Immune Response and Chronic Wound Microenvironment: Influence of Mesenchymal Stromal\/Stem Cells\u2019, J Immunol Res, 2021: 6649314","DOI":"10.1155\/2021\/6649314"},{"key":"6244_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2643-3230.BCD-21-0050","volume":"3","author":"AA Petti","year":"2022","unstructured":"Petti AA, Khan SM, Xu Z, Helton N, Fronick CC, Fulton R, Ramakrishnan SM, Nonavinkere Srivatsan S, Heath SE, Westervelt P, Payton JE, Walter MJ, Link DC, DiPersio J, Miller C, Ley TJ (2022) Genetic and transcriptional contributions to relapse in normal karyotype acute myeloid leukemia. Blood Cancer Discov 3:32\u201349","journal-title":"Blood Cancer Discov"},{"key":"6244_CR50","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/2211-5463.13352","volume":"12","author":"J Phetfong","year":"2022","unstructured":"Phetfong J, Tawonsawatruk T, Kamprom W, Ontong P, Tanyong D, Borwornpinyo S, Supokawej A (2022) Bone marrow-mesenchymal stem cell-derived extracellular vesicles affect proliferation and apoptosis of leukemia cells in vitro. FEBS Open Bio 12:470\u2013479","journal-title":"FEBS Open Bio"},{"key":"6244_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11033-024-10200-9","volume":"52","author":"L Rajabi","year":"2025","unstructured":"Rajabi L, Ebrahimdoost M, Mohammadi SA, Samarkhazan HS, Khamisipour G, and Mojtaba Aghaei (2025) Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53. Mol Biol Rep 52:102","journal-title":"Mol Biol Rep"},{"key":"6244_CR52","doi-asserted-by":"crossref","unstructured":"Raoufi A, Samarkhazan HS, Nouri S, Khaksari MN, Sourki PA Omolbanin Sargazi Aval, Behzad Baradaran, and Mojtaba Aghaei. 2025. \u2018Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets\u2019. Clin Experimental Med, 25: 73","DOI":"10.1007\/s10238-025-01588-0"},{"key":"6244_CR53","doi-asserted-by":"crossref","unstructured":"Saadh MJ, Hussein A, Bayani A, Dastafkan S, Amiri M, Akbari A, Shahsavan S, Soleimani H, Samarkhazan and V. Shirani Asl. 2025. \u2018Mesenchymal stem cell-derived exosomes: a novel therapeutic frontier in hematological disorders\u2019. Med Oncol, 42: 199","DOI":"10.1007\/s12032-025-02742-0"},{"key":"6244_CR54","doi-asserted-by":"crossref","unstructured":"Safi R, Mohsen-Kanson T, Kouzi F, El-Saghir J, Dermesrobian V, Zugasti I, Zibara K, Men\u00e9ndez P, El Hajj H, El-Sabban M (2024) \u2018Direct Interaction Between CD34(+) Hematopoietic Stem Cells and Mesenchymal Stem Cells Reciprocally Preserves Stemness\u2019. Cancers (Basel), 16","DOI":"10.20944\/preprints202409.2390.v1"},{"key":"6244_CR55","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41467-020-14590-9","volume":"11","author":"Y Sheng","year":"2020","unstructured":"Sheng Y, Yu C, Liu Y, Hu C, Ma R, Lu X, Ji P, Chen J, Mizukawa B, Huang Y, Licht JD, Qian Z (2020) FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML. Nat Commun 11:928","journal-title":"Nat Commun"},{"key":"6244_CR56","doi-asserted-by":"publisher","first-page":"123125","DOI":"10.1016\/j.lfs.2024.123125","volume":"358","author":"O Sogbein","year":"2024","unstructured":"Sogbein O, Paul P, Umar M, Chaari A, Batuman V, Rohit Upadhyay (2024) Bortezomib in cancer therapy: mechanisms, side effects, and future proteasome inhibitors. Life Sci 358:123125","journal-title":"Life Sci"},{"key":"6244_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s11033-025-10527-x","volume":"52","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H, Zehtabcheh S, Peyvasteh S, Mohammadi MH (2025) C-type lectin-like molecule-1 as a diagnostic, prognostic, and therapeutic marker in leukemia. Mol Biol Rep 52:464","journal-title":"Mol Biol Rep"},{"key":"6244_CR58","doi-asserted-by":"crossref","unstructured":"Soleimani Samarkhazan, Hamed S, Zehtabcheh HR, Seraji, Safedin H, Beqaj Shamim Tayefeh, Mohammad Hossein Mohammadi, and Mojtaba Aghaei. 2025. \u2018Unveiling the potential of CLL-1: a promising target for AML therapy\u2019. Biomark Res, 13: 28","DOI":"10.1186\/s40364-025-00738-6"},{"key":"6244_CR59","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S (2010) Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 70:68\u201377","journal-title":"Cancer Res"},{"key":"6244_CR60","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/s41375-021-01218-0","volume":"35","author":"J Stomper","year":"2021","unstructured":"Stomper J, Rotondo JC, Greve G, L\u00fcbbert M (2021) Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies. Leukemia 35:1873\u20131889","journal-title":"Leukemia"},{"key":"6244_CR61","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.apsb.2023.05.007","volume":"13","author":"L Sun","year":"2023","unstructured":"Sun L, Yang N, Chen B, Bei Y, Kang Z, Zhang C, Zhang N, Xu P, Yang W, Wei J, Ke J, Sun W, Li X, Shen P (2023a) A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. Acta Pharm Sin B 13:3027\u20133042","journal-title":"Acta Pharm Sin B"},{"key":"6244_CR62","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.apsb.2023.05.007","volume":"13","author":"L Sun","year":"2023","unstructured":"Sun L, Yang N, Chen B, Bei Y, Kang Z, Zhang C, Zhang N, Xu P, Yang W, Wei J, Ke J, Sun W, Li X, Pingping Shen (2023b) A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. Acta Pharm Sinica B 13:3027\u20133042","journal-title":"Acta Pharm Sinica B"},{"key":"6244_CR63","doi-asserted-by":"publisher","first-page":"21713","DOI":"10.18632\/oncotarget.7964","volume":"7","author":"P Takam Kamga","year":"2016","unstructured":"Takam Kamga P, Bassi G, Cassaro A, Midolo M, Di Trapani M, Gatti A, Carusone R, Resci F, Perbellini O, Gottardi M, Bonifacio M, Nwabo AH, Kamdje A, Ambrosetti, Krampera M (2016) Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia. Oncotarget 7:21713\u201321727","journal-title":"Oncotarget"},{"key":"6244_CR64","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.gendis.2020.10.006","volume":"9","author":"L Tan","year":"2022","unstructured":"Tan L, Liu X, Dou H, Hou Y (2022) Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment - specific factors involved in the regulation of MSC plasticity. Genes Dis 9:296\u2013309","journal-title":"Genes Dis"},{"key":"6244_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","volume":"36","author":"S Tettamanti","year":"2022","unstructured":"Tettamanti S, Pievani A, Biondi A, Dotti G, Serafini M (2022) Catch me if you can: how AML and its niche escape immunotherapy. Leukemia 36:13\u201322","journal-title":"Leukemia"},{"key":"6244_CR66","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1159\/000323973","volume":"26","author":"K Tian","year":"2010","unstructured":"Tian K, Yang S, Ren Q, Han Z, Lu S, Ma F, Zhang L, Han Z (2010) p38 MAPK contributes to the growth Inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells. Cell Physiol Biochem 26:799\u2013808","journal-title":"Cell Physiol Biochem"},{"key":"6244_CR67","doi-asserted-by":"publisher","first-page":"1320497","DOI":"10.3389\/fimmu.2023.1320497","volume":"14","author":"C Tomasoni","year":"2023","unstructured":"Tomasoni C, Arsuffi C, Donsante S, Corsi A, Riminucci M, Biondi A, Pievani A, Serafini M (2023a) AML alters bone marrow stromal cell osteogenic commitment via Notch signaling. Front Immunol 14:1320497","journal-title":"Front Immunol"},{"key":"6244_CR68","doi-asserted-by":"crossref","unstructured":"Tomasoni C, Arsuffi C, Donsante S, Corsi A, Riminucci M, Biondi A, Pievani A, and Marta Serafini (2023b). \u2018AML alters bone marrow stromal cell osteogenic commitment via Notch signaling\u2019. Front Immunol, 14","DOI":"10.3389\/fimmu.2023.1320497"},{"key":"6244_CR69","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726\u2013736","journal-title":"Nat Rev Immunol"},{"key":"6244_CR70","doi-asserted-by":"crossref","unstructured":"Ullah I, Subbarao RB, Rho GJ (2015) \u2018Human mesenchymal stem cells - current trends and future prospective\u2019. Biosci Rep, 35","DOI":"10.1042\/BSR20150025"},{"key":"6244_CR71","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.immuni.2018.03.024","volume":"48","author":"Q Wei","year":"2018","unstructured":"Wei Q, Frenette PS (2018) Niches for hematopoietic stem cells and their progeny. Immunity 48:632\u2013648","journal-title":"Immunity"},{"key":"6244_CR72","doi-asserted-by":"crossref","unstructured":"Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, Wartman LD, Lamprecht TL, Liu F, Xia J, Kandoth C, Fulton RS, McLellan MD, Dooling DJ, Wallis JW, Chen K, Harris CC, Schmidt HK, Kalicki-Veizer JM, Lu C, Zhang Q, Lin L, O\u2019Laughlin MD, McMichael JF, Delehaunty KD, Fulton LA, Magrini VJ, McGrath SD, Demeter RT, Vickery TL, Hundal J, Cook LL, Swift GW, Reed JP, Alldredge PA, Wylie TN, Walker JR, Watson MA, Heath SE, Shannon WD, Varghese N, Nagarajan R, Payton JE, Baty JD, Kulkarni S, Klco JM, Tomasson MH, Westervelt P, Walter MJ, Graubert TA, J. F., DiPersio L, Ding ER, Mardis and R. K. Wilson. 2012. \u2018The origin and evolution of mutations in acute myeloid leukemia\u2019, Cell, 150: 264\u2013\u200978","DOI":"10.1016\/j.cell.2012.06.023"},{"key":"6244_CR73","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1097\/CM9.0000000000001138","volume":"133","author":"YC Xu","year":"2020","unstructured":"Xu YC, Lin YS, Zhang L, Lu Y, Sun YL, Fang ZG, Li ZY, Fan RF (2020) MicroRNAs of bone marrow mesenchymal stem cell-derived exosomes regulate acute myeloid leukemia cell proliferation and apoptosis. Chin Med J (Engl) 133:2829\u20132839","journal-title":"Chin Med J (Engl)"},{"key":"6244_CR74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40364-025-00786-y","volume":"13","author":"S Zehtabcheh","year":"2025","unstructured":"Zehtabcheh S, Soleimani Samarkhazan H, Asadi M, Zabihi M, Parkhideh S, Mohammadi MH (2025) Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies. Biomark Res 13:73","journal-title":"Biomark Res"},{"key":"6244_CR77","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s13287-021-02444-0","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Chi Y, Wei Y, Zhang W, Wang F, Zhang L, Zou L, Song B, Zhao X, Han Z (2021a) Bone marrow-derived mesenchymal stem\/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality. Stem Cell Res Ther 12:365","journal-title":"Stem Cell Res Ther"},{"key":"6244_CR78","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s13287-021-02444-0","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Chi Y, Wei Y, Zhang W, Wang F, Zhang L, Zou L, Song B, Zhao X, Zhongchao Han (2021b) Bone marrow-derived mesenchymal stem\/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality. Stem Cell Res Ther 12:365","journal-title":"Stem Cell Res Ther"},{"key":"6244_CR76","doi-asserted-by":"crossref","unstructured":"Zhang C, Wang H, Aji T, Li Z, Li Y, Ainiwaer A, Rousu Z, Li J, Wang M, Deng B, Adilai duolikun, Xuejiao Kang, Xuran Zheng, Qian Yu, Yingmei Shao, Zhang W, Vuitton DA (2024b) Zhigang Tian, Haoyu Sun, and Hao Wen. \u2018Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade\u2019, Nature Communications, 15: 6345","DOI":"10.1038\/s41467-024-50754-7"},{"key":"6244_CR75","doi-asserted-by":"crossref","unstructured":"Zhang C, Wang H, Aji T, Li Z, Li Y, Ainiwaer A, Rousu Z, Li J, Wang M, Deng B, Duolikun A, Kang X, Zheng X, Yu Q, Shao Y, Zhang W, Vuitton DA, Tian Z, Sun H, Wen H 2024a. \u2018Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade (15 words)\u2019. Nat Commun, 15: 6345","DOI":"10.1038\/s41467-024-50754-7"},{"key":"6244_CR79","doi-asserted-by":"publisher","first-page":"982241","DOI":"10.3389\/fgene.2022.982241","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhao J, Zhong M, Zhang Q, Yan F, Feng Y, Guo Y (2022) The expression and methylation of PITX genes is associated with the prognosis of head and neck squamous cell carcinoma. Front Genet 13:982241","journal-title":"Front Genet"},{"key":"6244_CR80","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/leu.2008.384","volume":"23","author":"Y Zhu","year":"2009","unstructured":"Zhu Y, Sun Z, Han Q, Liao L, Wang J, Bian C, Li J, Yan X, Liu Y, Shao C, Zhao RC (2009) Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 23:925\u2013933","journal-title":"Leukemia"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06244-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:11:30Z","timestamp":1757196690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06244-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["6244"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06244-4","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}